bf/NASDAQ:BVS_icon.jpeg

COM:BIOVENTUS

Bioventus

  • Stock

USD

Last Close

11.51

22/11 21:00

Market Cap

375.94M

Beta: -

Volume Today

287.88K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
30.93M
-
27.36M
-
28.22M
3.15%
45.40M
60.88%
73.55M
61.99%
88.37M
20.15%
average payables
6.88M
-
7.32M
-
5.43M
25.84%
10.67M
96.44%
27.23M
155.26%
30.29M
11.24%
average receivables
50.79M
-
78.85M
-
86.71M
9.96%
106.62M
22.97%
130.80M
22.68%
129.72M
0.83%
book value per share
3.19
-
3.46
8.37%
2.61
24.47%
2.57
1.57%
3.77
46.79%
7.71
104.25%
5.16
33.08%
capex per share
-0.11
-
-0.37
227.72%
-0.13
64.27%
-0.11
18.56%
-0.15
37.63%
-0.55
265.66%
-0.12
77.43%
-0.19
51.62%
capex to depreciation
-0.26
-
-0.72
178.12%
-0.22
68.87%
-0.21
7.86%
-0.28
32.74%
-0.72
162.28%
-0.21
70.72%
-0.17
18.40%
capex to operating cash flow
-2.31
-
-1.38
40.37%
-0.39
71.47%
-0.13
65.90%
-0.20
52.76%
-0.29
40.52%
-0.32
11.34%
0.85
365.47%
capex to revenue
-0.03
-
-0.09
213.53%
-0.03
65.79%
-0.02
35.28%
-0.02
29.15%
-0.06
162.45%
-0.02
73.43%
-0.02
31.52%
cash per share
0.28
-
0.09
68.62%
0.77
764.12%
1.16
50.84%
2.30
98.60%
0.74
67.97%
0.52
29.76%
days of inventory on hand
130.49
-
172.71
32.35%
118.80
31.21%
109.68
7.68%
121.28
10.57%
175.64
44.83%
172.20
1.96%
928.59K
539,164.79%
days payables outstanding
26.33
-
41.08
56.01%
35.59
13.37%
25.85
27.37%
18.42
28.76%
48.16
161.52%
75.70
57.19%
234.23K
309,299.28%
days sales outstanding
70.74
-
78.44
10.89%
82.99
5.80%
91.35
10.08%
100.33
9.84%
105.85
5.50%
97.39
7.99%
448.18K
460,087.60%
debt to assets
0.40
-
0.39
2.62%
0.44
13.77%
0.42
4.77%
0.38
9.09%
0.29
23.41%
0.30
4.38%
0.49
59.87%
debt to equity
0.96
-
0.98
1.74%
1.34
36.84%
1.38
3.23%
1.32
4.35%
0.78
41.15%
1.32
69.44%
2.27
72.24%
dividend yield
0.01
-
0.01
16.45%
0.03
221.15%
0.00
98.45%
earnings yield
-0.02
-
-0.01
42.33%
-0.03
164.43%
-0.01
64.21%
0.01
156.12%
0.02
253.46%
0.01
50.98%
-1.33
12,087.98%
enterprise value
1.22B
-
1.25B
2.32%
1.22B
2.52%
1.20B
1.52%
825.70M
31.31%
1.18B
42.50%
546.48M
53.55%
357.88M
34.51%
enterprise value over ebitda
38.71
-
32.41
16.26%
21.65
33.21%
19.34
10.68%
15.05
22.18%
22.37
48.66%
17.56
21.52%
9.42K
53,545.42%
ev to operating cash flow
81.00
-
66.18
18.29%
27.01
59.18%
29.52
9.30%
11.50
61.05%
51.18
345.01%
-40.37
178.88%
20.44
150.62%
ev to sales
5.04
-
4.94
2.02%
3.82
22.53%
3.53
7.59%
2.57
27.25%
2.73
6.21%
1.07
60.92%
3.58K
335,279.65%
free cash flow per share
-0.06
-
-0.10
58.61%
0.21
300.63%
0.70
240.88%
0.58
17.26%
1.36
133.05%
0.26
80.66%
-0.41
255.60%
free cash flow yield
-0.00
-
-0.01
58.61%
0.01
300.63%
0.04
240.88%
0.03
17.26%
0.07
133.05%
0.02
74.36%
-0.16
963.83%
graham net net
-3.39
-
-4.16
22.85%
-3.35
19.45%
-3.32
0.96%
-4.85
45.91%
-8.79
81.42%
-13.93
58.46%
graham number
4.08
-
6.91
69.28%
3.59
48.01%
2.67
25.68%
6.08
127.79%
5.28
13.09%
20.08
280.12%
income quality
-0.12
-
-1.17
852.97%
-0.55
52.64%
10.17
1,933.62%
5.02
50.66%
4.88
2.81%
2.40
50.82%
0.06
97.35%
intangibles to total assets
0
-
0.75
Infinity%
0.78
2.91%
0.65
16.44%
0.56
12.99%
0.49
13.38%
0.69
40.80%
0.77
11.52%
0.60
21.22%
interest coverage
-0.70
-
0.00
100.24%
-1.17
69,866.59%
1.33
214.12%
1.45
8.66%
2.18
50.67%
15.94
631.75%
-1.38
108.68%
interest debt per share
3.29
-
3.64
10.82%
3.85
5.55%
3.95
2.59%
5.26
33.17%
6.03
14.64%
7.23
20.00%
inventory turnover
2.80
-
2.11
24.45%
3.07
45.38%
3.33
8.32%
3.01
9.56%
2.08
30.95%
2.12
2.00%
0.00
99.98%
invested capital
0.96
-
0.98
1.74%
1.34
36.84%
1.38
3.23%
1.32
4.35%
0.78
41.15%
1.32
69.44%
2.27
72.24%
market cap
1.07B
-
1.07B
0%
1.07B
0%
1.07B
0%
1.07B
0%
724.16M
32.23%
862.86M
19.15%
160.23M
81.43%
net current asset value
-157.70M
-
-195.59M
24.02%
-149.10M
23.77%
-143.76M
3.58%
-138.51M
3.65%
-428.97M
209.70%
-759.74M
77.11%
-321.79M
57.64%
net debt to ebitda
4.91
-
4.75
3.21%
2.70
43.24%
2.15
20.40%
1.85
13.80%
5.97
222.35%
12.41
108.02%
9.42K
75,798.68%
net income per share
-0.40
-
-0.23
42.33%
-0.61
164.43%
-0.22
64.21%
0.12
156.12%
0.44
253.46%
0.16
63.02%
-3.48
2,259.33%
operating cash flow per share
0.05
-
0.27
449.62%
0.34
25.22%
0.81
138.83%
0.73
9.90%
1.90
160.23%
0.39
79.73%
-0.22
157.11%
payables turnover
13.86
-
8.88
35.90%
10.26
15.44%
14.12
37.68%
19.82
40.36%
7.58
61.76%
4.82
36.38%
0.00
99.97%
receivables turnover
5.16
-
4.65
9.82%
4.40
5.48%
4.00
9.15%
3.64
8.95%
3.45
5.21%
3.75
8.69%
0.00
99.98%
research and ddevelopement to revenue
0.05
-
0.04
17.20%
0.06
49.20%
0.03
56.38%
0.03
28.15%
0.03
7.32%
0.04
26.68%
0.05
14.64%
0.03
48.67%
return on tangible assets
-0.12
-
-0.31
156.29%
-0.08
74.86%
0.03
142.45%
0.06
95.12%
0.03
61.42%
-0.67
2,763.27%
revenue per share
4.18
-
4.37
4.53%
4.56
4.43%
5.74
25.83%
6.11
6.57%
8.52
39.32%
7.24
15.06%
8.34
15.29%
roe
-0.07
-
-0.18
144.01%
-0.08
52.62%
0.05
157.02%
0.12
140.79%
0.02
81.90%
-0.67
3,326.97%
roic
0.00
-
-0.05
71,209.63%
0.05
218.15%
0.08
40.42%
0.06
22.43%
0.03
54.06%
-0.04
243.83%
sales general and administrative to revenue
shareholders equity per share
3.19
-
3.46
8.37%
2.61
24.47%
2.57
1.57%
3.77
46.79%
7.71
104.25%
5.16
33.08%
stock based compensation to revenue
0.02
-
0.02
6.54%
0.04
84.29%
0.04
6.58%
0.03
28.97%
0.03
1.33%
-0.01
133.29%
0.03
427.93%
tangible asset value
-146.80M
-
-185.51M
26.37%
-141.56M
23.69%
-120.69M
14.74%
-97.29M
19.39%
-309.03M
217.63%
-712.15M
130.45%
-268.69M
62.27%
tangible book value per share
-2.64
-
-3.33
26.37%
-2.54
23.69%
-2.17
14.74%
-2.58
18.95%
-5.19
101.08%
-11.60
123.54%
working capital
43.08M
-
11.74M
72.75%
82.93M
606.53%
94.02M
13.38%
89.20M
5.12%
82.24M
7.80%
-31.44M
138.23%
92.50M
394.20%

All numbers in USD (except ratios and percentages)